-
leading to AD, 2) to improve early detection and longitudinal monitoring by combining neuroimaging (i.e., MRI, PET and MEG) and fluid (i.e., CSF and plasma) biomarkers and 3) to analyze genomic data
-
Position Summary Project summary: The objective of this project is to identify novel brain and neurological biomarkers for integrative and non-pharmacological treatment of chronic sickle pain conditions
-
leading to AD, 2) to improve early detection and longitudinal monitoring by combining neuroimaging (i.e., MRI, PET and MEG) and fluid (i.e., CSF and plasma) biomarkers and 3) to analyze genomic data
-
related disorders (ADRD). The Lab’s overarching goals are 1) to achieve a better understanding of the complex causes and mechanisms leading to ADRD, 2) to improve early detection and longitudinal monitoring